[Gilead Sciences](https://www.gilead.com)

September 2027 (Application deadline, projected)

Award size and duration vary by project scope, scale, and country; up to 10% of budget may be dedicated to impact reporting.

Supports global (excluding US) community initiatives to enhance education, awareness, and action to eliminate viral hepatitis as a public health threat by 2030.

--- ## Description The ALL4LIVER Grant, established by Gilead Sciences, is a biennial global initiative (excluding the United States) aimed at supporting local communities to enhance education, awareness, and collective action around viral hepatitis. The program aligns with the World Health Organization’s goal to eliminate viral hepatitis as a public health threat by 2030 by empowering communities, strengthening healthcare systems, and improving access to essential services. Projects should focus on testing, linkage to care, and advocacy to prioritize viral hepatitis on public health agendas. --- ## Due Dates - September 2027 (anticipated/projected application deadline) *All dates are projected based on the annual cycle; check the program page for updates.* --- ## Funding Amount - Award size and duration are determined based on the project’s medium, scale, duration, and local cost of living. - Up to 10% of the requested budget may be allocated to impact reporting. - Funding cannot be used for medications, direct purchase of equipment, medical expenses, deficits/debt, basic biomedical/clinical research, or lobbying. --- ## Eligibility - Open to organizations worldwide, excluding the United States. - Eligible applicants include community groups, nonprofits, and organizations with a proven track record and good governance. - Projects must: - Demonstrate clear deliverables and a sustainable, scalable design. - Engage stakeholders to foster multistakeholder collaboration. - Include measurable impact metrics. - Ineligible recipients: individuals, individual healthcare providers, policymakers, physician group practices, and organizations that discriminate based on race, color, gender, religion, disability, sexual orientation, gender identity, or expression. - Projects must conclude before the next funding cycle as specified in the call. --- ## Application Process - Proposals must be submitted online through the [Gilead grant portal](https://gilead-grants.steeprockinc.com/). - Submissions must be in English; support is available for applicants needing assistance. - Applicants should specify which focus area their proposal addresses (testing, linkage to care, or advocacy). - Only one organization will receive funds as the project coordinator, but collaborations are encouraged. - Review is conducted by an external global panel of experts, followed by a Gilead review committee for final decisions. - Typical review time is 6–12 weeks after submission. --- ## Additional Information - The grant focuses on projects that drive testing, support linkage to care, and advocate for prioritizing viral hepatitis on public health agendas. - Funding is not provided for basic biomedical or clinical research, or for activities that directly advance Gilead’s business interests. - Proposals must comply with all relevant local laws and regulations. --- ## External Links - [ALL4LIVER Grant Program Page](https://www.gileadall4liver.com/) - [About the Grant](https://www.gileadall4liver.com/about-the-grant/) - [Gilead Grant Portal](https://gilead-grants.steeprockinc.com/) - [FAQs](https://www.gileadall4liver.com/faqs) - [Gilead Corporate Giving Terms & Conditions](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/terms-and-conditions) --- ## Contact Information | Contact | Details | |----------------------|-----------------------------------------------------| | Email | [grants@gilead.com](mailto:grants@gilead.com) | | Phone | +1 (650) 574 3000 | | General Contact Page | [Contact Gilead Sciences](https://www.gilead.com/contact-us) | ---

ALL4LIVER

Sign in to see full grant listing